Tag: Real-World Data

By Vigilare Biopharma January 30, 2026Pharmacovigilance

Real-World Evidence (RWE) in Pharmacovigilance MAH Compliance and EMA’s 2026 Framework

The European Medicines Agency (EMA) is re-examining its approach to drug safety. The 2026 pharmacovigilance (PV) framework marks significant progress in using real-world evidence (RWE) to monitor medicines and inform regulatory decisions in the European

Read More
Deep-Dive-Best-Practices-for-Robust-Signal-Detection-and-Management
By Vigilare Biopharma September 13, 2025Pharmacovigilance

Deep Dive: Best Practices for Robust Signal Detection and Management in Real-World Data

In an era where real-world data (RWD) is reshaping pharmacovigilance, the ability to detect and manage safety signals effectively has become a cornerstone of regulatory compliance and patient protection. With data flowing from electronic health

Read More